The Centre for Health and the Public Interest (CHPI) has recently published a report on private finance initiatives (PFI). The report, intended for policy-makers, outlines five options for coping with PFI and its lasting effects, […]
Highlighting findings from the Royal College of Radiologists, ‘Clinical Radiology UK Workforce Census 2017 Report’, a recent BMJ news article calls attention to the rising expenditure by the NHS on outsourced radiology patient scans. With […]
The UK government will offer up to £86 million in funding to UK firms that work to develop ‘medical breakthroughs.’ Funds will go to small and medium sized enterprises (SMEs) that wish to develop and […]
The Times reports that The Association of the British Pharmaceutical Industry (ABPI) has warned that major drug companies may leave Britain if the NHS is not funded an additional £20 billion per year. The organisation […]
Piece from the Guardian pointing to an investigation by the competition authority into price fixing within the pharmaceutical industry. Actavis charged NHS 80% more for hydrocortisone tablets after incentivising rival Concordia not to launch its […]
The cost of drugs and other medical equipment is of growing concern to both public health systems and private health insurance companies. Regarding the former, pharmaceutical companies can push up the price of drugs in […]
Copyright: Corporate Welfare Watch 2017